NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

NIH now has a list – reviewed by NPR – of 130 of these awards from one part of the NIH, the National Institute of Allergy and ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

NIH-sponsored trial of candidate vaccine to prevent Lassa fever begins enrolling participants: Bethesda, Maryland Thursday, March 20, 2025, 18:00 Hrs [IST] A National Institutes o ...

In retrospect, it is hard to avoid the conclusion that Fauci, who proclaimed, "I represent science," purposefully lied and ...

How Infectious Disease Doctors Can Keep Up in a Rapidly Evolving Field As with most areas of medicine, advances in infectious diseases are accelerating at a rapid clip, and it’s understandable that as ...

Appili Therapeutics (APLIF) announced that, the Company along with its partners, have submitted applications for four new federal funding ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

Topical Steroid Withdrawal Diagnostic Criteria Defined by NIH Researchers - Criteria May Help Guide Treatment of Dermatitis ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.